Kohesio: discover EU projects in your region

   
more info
Start date: 1 January 2013
End date: 31 December 2022
Number of projects: 95
Total budget: 16 724 346,90 €
EU contribution: 8 820 218,97 €
Website: n/a
Country: European Commission Flag
Explore more: n/a
funds
ERDF: 8 820 218,97 €

1 - 15 of 95
PROJECTTOTAL BUDGETEU CONTRIBUTIONFUNDImprovement of research infrastructures in personalised medicine and development of innovative medicines with a view to health application in various pathologies, during the period 2014-2020. 6 431 189,50 € 3 215 594,80 € ERDF A multidisciplinary project to advance in basic mechanisms, diagnosis, prediction, and prevention of cardiac damage in reperfused acute myocardial infarction 535 500,00 € 291 579,75 € ERDF PLATFORM OF CLINICAL RESEARCH UNITS AND CLINICAL TRIALS 315 000,00 € 171 517,50 € ERDF IMMUNOPHARMACOLOGIC MODULATION OF THE SYSTEMIC INFLAMMATION ASSOCIATED WITH METABOLIC DISORDERS. NEW THERAPEUTIC TARGETS AND SYNTHESIS OF NEW PHARMACEUTICALS 302 500,00 € 164 711,25 € ERDF MATERNAL CONTRIBUTION IN PATHOGENESIS OF LATE GESTATIONAL DISEASES SUCH AS PREECLAMPSIA. 254 100,00 € 138 357,45 € ERDF Spanish Clinical Research Network (SCReN) 242 250,00 € 131 905,12 € ERDF PHARMACOLOGICAL MODULATION OF THE IMMUNE SYSTEM AS KEY DIANA IN THE PREVENTION OF CARDIOVASCULAR DISEASE ASSOCIATED WITH METABOLIC DISORDERS. SYNTHESIS OF NOVEL PHARMACOS 205 700,00 € 112 003,65 € ERDF METABOLOMIC STUDY OF HOST-MICROBIOTA INTESTINAL INTERACTION IN CARDIOMETABOLICAL DISEASE. ROLE IN EARLY DETECTION, PREVENTION AND TREATMENT. 193 600,00 € 105 415,20 € ERDF Cardiovascular Network 184 434,80 € 100 424,74 € ERDF PHARMACOLOGICAL MODULATION OF INFLAMMATORY-REMODELED SIGNALISATION BY ISOFORM-SELECTIVE PDE4 INHIBITORS AND COMPARATORS IN RELEVANT IN VITRO HUMAN MODELS IN COPD 181 500,00 € 98 826,75 € ERDF MATERNAL TRANSCRIPTOMIC REGULATION OF PRE-IMPLANTORY EMBRYO. NEW MECHANISM FOR STUDYING THE ORIGIN OF COMPLEX ADULT DISEASES: OBESITY AND/OR TOBACCO EXPOSURE 169 400,00 € 92 238,30 € ERDF Identification of variations in sequence and methylation and hydroxymethylation in the exome associated with the development of type 2 diabetes 162 000,00 € 88 209,00 € ERDF Identification of genetic variants that are protective against the development of type 2 diabetes in octogenarians. 162 000,00 € 88 209,00 € ERDF NATIONAL BIOBANK NETWORK 161 739,12 € 88 066,95 € ERDF Metals and subclinical arteriosclerosis: role of genetic and epigenetic variation in candidate genes 161 500,00 € 87 936,75 € ERDF